| Literature DB >> 35353859 |
Carlos Eduardo Girasol1, Guilherme de Araújo Braz2, Luciano Bachmann3, Jonathan Celli4, Rinaldo Roberto de Jesus Guirro1.
Abstract
PURPOSE: Daily clinical use of therapeutic light sources can lead to changes in light emission stability with potentially significant consequences for usage in photomedicine treatment. The aim of this study was to evaluate the average and maximum power and to describe the beam diameter of different low-power laser photobiomodulation devices in clinical use in Brazil.Entities:
Mesh:
Year: 2022 PMID: 35353859 PMCID: PMC8967059 DOI: 10.1371/journal.pone.0266193
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Diagram of the experimental setup for the beam profile measurement.
LP: Laser probe; OF: Optical Fiber; TS: Translation Stage.
Characterization of the evaluated equipment (n = 24).
| Equipment | Wavelength (nm) | Purchased time (months) | Last maintenance (months) | Average time of use/week (minutes) | Average power measured (mW) | Percentage of the power predicted in manual |
|---|---|---|---|---|---|---|
| Ibramed—Laserpulse | 904 | >120 | 12 to 24 | <30 | 41.9 | 60% |
| Ibramed—Laserpulse | 450 | >120 | 12 to 24 | <30 | 62.37 | 89% |
| Ibramed–Laserpulse | 660 | >120 | 12 to 24 | <30 | 33.06 | 110% |
| Ibramed–Laserpulse | 830 | >120 | 12 to 24 | <30 | 33.06 | 110% |
| Ibramed—Laserpulse | 830 | >120 | 12 to 24 | <30 | 0.61 | 2% |
| Ibramed–Laserpulse | 830 | >120 | 12 to 24 | <30 | 40.28 | 134% |
| Ibramed—Laserpulse | 830 | >120 | over 36 | <30 | 33.63 | 112% |
| Ibramed–Laserpulse | 830 | >120 | over 36 | <30 | 33.77 | 113% |
| Ibramed–Laserpulse | 830 | >120 | over 36 | <30 | 30.40 | 101% |
| Ibramed–Laserpulse | 660 | >120 | over 36 | <30 | 18.08 | 60% |
| Ibramed–Laserpulse | 660 | >120 | over 36 | <30 | 16.93 | 56% |
| Ibramed–Laserpulse | 904 | >120 | over 36 | <30 | 52.08 | 74% |
| Ibramed–Laserpulse | 660 | >120 | never | <30 | 34.28 | 114% |
| Ibramed–Laserpulse | 660 | >120 | never | <30 | 27.13 | 90% |
| Ibramed–Laserpulse | 904 | >120 | never | <30 | 50.04 | 71% |
| Ibramed–Laserpulse | 904 | >120 | never | <30 | 41.86 | 60% |
| Ibramed–Laserpulse | 904 | >120 | never | <30 | 43.08 | 62% |
| Ibramed–Laserpulse | 830 | >120 | never | <30 | 31.25 | 104% |
| Ibramed—Antares | 660 | <12 | <12 of acquisition | <30 | 42 | 105% |
| Ibramed—Antares | 904 | <12 | <12 of acquisition | <30 | 72.1 | 103% |
| HTM–Fluence | 904 | ±96 | 12 to 24 | <30 | 7.64 | 59% |
| HTM–Fluence | 904 | ±96 | 12 to 24 | 30 to 90 | 11.4 | 88% |
| DMC–Therapy XT | 808 | <12 | <12 of acquisition | 30 to 90 | 95.5 | 96% |
| DMC–Therapy XT | 660 | <12 | <12 of acquisition | 30 to 90 | 103 | 103% |
1 2800 Dr. Carlos Burgos Ave, Amparo, São Paulo, Brazil
2 831 Sebastião Moraes St, São Carlos, São Paulo, Brazil
3 209 Rio Nilo Ave, Amparo, São Paulo, Brazil.
Fig 2The average power of different equipment against nominal power.
Fig 3Laser beam diameters in different equipment and different application distances.
Z-Z0 is the different analysis points (0, 3, 6, 9, 12, and 15 cm) of the laser emitter; r is the radius for the highlighted point.
The intercept and slope for different inclination in evaluated equipment.
| Equipment | Intercept | Slope |
|---|---|---|
| Ibramed—Laserpulse 450nm | 0.220 (0.002) | 0.042 (0.001) |
| Ibramed—Antares 660nm | 0.091 (0.020) | 0.029 (0.003) |
| Ibramed—Laserpulse 660nm | 0.158 (0.002) | 0.027 (0.000) |
| Ibramed—Laserpulse 660nm | 0.154 (0.004) | 0.056 (0.002) |
| Ibramed—Laserpulse 660nm | 0.136 (0.009) | 0.053 (0.006) |
| Ibramed—Laserpulse 660nm | 0.128 (0.005) | 0.029 (0.001) |
| Ibramed—Laserpulse 660nm | 0.242 (0.005) | 0.043 (0.001) |
| DMC–Therapy XT 660nm | 0.123 (0.018) | 0.031 (0.005) |
| Ibramed—Laserpulse 830nm | 0.119 (0.003) | 0.032 (0.000) |
| Ibramed—Laserpulse 830nm | 0.229 (0.006) | 0.050 (0.002) |
| Ibramed—Laserpulse 830nm | 0.117 (0.002) | 0.015 (0.001) |
| Ibramed—Laserpulse 830nm | 0.166 (0.004) | 0.011 (0.001) |
| Ibramed—Laserpulse 830nm | 0.157 (0.007) | 0.037 (0.002) |
| DMC–Therapy XT 808nm | 0.141 (0.054) | 0.039 (0.006) |
| Ibramed—Laserpulse 904nm | 0.159 (0.013) | 0.052 (0.003) |
| Ibramed—Laserpulse 904nm | 0.175 (0.009) | 0.049 (0.002) |
| Ibramed—Laserpulse 904nm | 0.156 (0.005) | 0.037 (0.001) |
| Ibramed—Laserpulse 904nm | 0.208 (0.002) | 0.043 (0.001) |
| Ibramed—Laserpulse 904nm | 0.186 (0.011) | 0.041 (0.002) |
| Ibramed—Antares 830nm | 0.269 (0.008) | 0.054 (0.002) |
| HTM–Fluence 904nm | 0.346 (0.038) | 0.034 (0.008) |
1 2800 Dr. Carlos Burgos Ave, Amparo, São Paulo, Brazil
2 831 Sebastião Moraes St, São Carlos, São Paulo, Brazil; O
3 209 Rio Nilo Ave, Amparo, São Paulo, Brazil.
Fig 4Beam geometry of three different emitting sources of the same brand and model.
Influence of sequential irradiation time on the average and maximum power evaluated.
| Outcomes | Power | Comparison of means | |
|---|---|---|---|
| 830–3 Min | 31.13 (SD 11.82) | 29.60 (SD 13.14) | |
| 830–3 Min | 30.20 (SD 11.68) | 28.77 (SD 12.84) | |
| 904–3 Min | 41.92 (SD 22.01) | 41.08 (SD 21.88) | |
| 904–3 Min | 41.09 (SD 21.70) | 40.02 (SD 21.23) | |
| D830 | 3.33 (SD 3.33) | 3.25 (SD 3.92) | |
| D830 | 3.33 (SD 2.88) | 3.25 (SD 2.05) | |
SD: Standard Deviation; p: p-value; D830: The difference between 830 (1 Min) and 830 (3 Min); D904: The difference between 904 (1 Min) and 904 (3 Min)
*statistically significant.